FOLFOX-4 REGIMEN AS ADJUVANT TREATMENT OF RADICALLY RESECATED GASTRIC CANCER PATIENTS

被引：0
|
作者：
Lucia, Cannella [1 ]
Alfonso, De Stefano [1 ]
Antonella, Prudente [1 ]
Carolina, Cimminiello [1 ]
Elide, Matano [1 ]
Roberto, Bianco [1 ]
Chiara, Carlomagno [1 ]
Anna, Crispo [1 ]
Sabino, De Placido [1 ]
机构：
[1] Univ Naples Federico 2, Dipartimento Endocrinol & Oncol Mol & Clin, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] FOLFOX-4 Chemotherapy for Patients With Unresectable or Relapsed Peritoneal Pseudomyxoma
    Pietrantonio, Filippo
    Maggi, Claudia
    Fanetti, Giuseppe
    Iacovelli, Roberto
    Di Bartolomeo, Maria
    Ricchini, Francesca
    Deraco, Marcello
    Perrone, Federica
    Baratti, Dario
    Kusamura, Shigeki
    Tamborini, Elena
    Castano, Alessandra
    Consonni, Paola Valentina
    Bossi, Ilaria
    Gavazzi, Cecilia
    Milione, Massimo
    Pelosi, Giuseppe
    de Braud, Filippo
    ONCOLOGIST, 2014, 19 (08): : 845 - 850
  • [42] FOLFOX versus EOX as a neoadjuvant chemotherapy regimen for patients with advanced gastric cancer
    Chen, Wenjun
    Shen, Jianguo
    Pan, Tao
    Hu, Wenxian
    Jiang, Zinong
    Yuan, Xiaoming
    Wang, Linbo
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (02) : 461 - 467
  • [43] Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
    Annamaria Ruzzo
    Francesco Graziano
    Francesca Galli
    Fabio Galli
    Eliana Rulli
    Sara Lonardi
    Monica Ronzoni
    Bruno Massidda
    Vittorina Zagonel
    Nicoletta Pella
    Claudia Mucciarini
    Roberto Labianca
    Maria Teresa Ionta
    Irene Bagaloni
    Enzo Veltri
    Pietro Sozzi
    Sandro Barni
    Vincenzo Ricci
    Luisa Foltran
    Mario Nicolini
    Edoardo Biondi
    Annalisa Bramati
    Daniele Turci
    Silvia Lazzarelli
    Claudio Verusio
    Francesca Bergamo
    Alberto Sobrero
    Luciano Frontini
    Mauro Magnani
    Scientific Reports, 9
  • [44] Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy
    Ruzzo, Annamaria
    Graziano, Francesco
    Galli, Francesca
    Galli, Fabio
    Rulli, Eliana
    Lonardi, Sara
    Ronzoni, Monica
    Massidda, Bruno
    Zagonel, Vittorina
    Pella, Nicoletta
    Mucciarini, Claudia
    Labianca, Roberto
    Ionta, Maria Teresa
    Bagaloni, Irene
    Veltri, Enzo
    Sozzi, Pietro
    Barni, Sandro
    Ricci, Vincenzo
    Foltran, Luisa
    Nicolini, Mario
    Biondi, Edoardo
    Bramati, Annalisa
    Turci, Daniele
    Lazzarelli, Silvia
    Verusio, Claudio
    Bergamo, Francesca
    Sobrero, Alberto
    Frontini, Luciano
    Magnani, Mauro
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [45] RECONSTRUCTIVE TREATMENT OF PATIENTS RADICALLY OPERATED ON FOR GASTRIC-CANCER
    LAKTIONOVA, AI
    GERASIMENKO, VN
    VON, KC
    VOPROSY ONKOLOGII, 1990, 36 (04) : 464 - 466
  • [46] FOLFOX-4 Regimen or Single-agent Gemcitabine as First-line Chemotherapy in Advanced Biliary Tract Cancer
    Novarino, Anna Maria Teresa
    Satolli, Maria Antonietta
    Chiappino, Isabella
    Giacobino, Alice
    Napoletano, Raffaella
    Ceccarelli, Manuela
    Ciccone, Gianni
    Schena, Marina
    Bertetto, Oscar
    Ciuffreda, Libero
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05): : 466 - 471
  • [47] Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer
    Ursina R. Teitelbaum
    Daniel G. Haller
    Nature Reviews Clinical Oncology, 2009, 6 : 250 - 251
  • [48] Second-line XELOX or FOLFOX-4 for metastatic colorectal cancer
    Teitelbaum, Ursina R.
    Haller, Daniel G.
    NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (05) : 250 - 251
  • [49] Modified FOLFIRI as Second-Line Chemotherapy after Failure of Modified FOLFOX-4 in Advanced Gastric Cancer
    Jeon, Eun Kyoung
    Hong, Sook Hee
    Kim, Tae Hee
    Jung, Seung Eun
    Park, Ji Chan
    Won, Hye-Sung
    Ko, Yoon-Ho
    Rho, Sang Young
    Hong, Young Seon
    CANCER RESEARCH AND TREATMENT, 2011, 43 (03): : 148 - 153
  • [50] Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy
    Ruzzo, Annamaria
    Graziano, Francesco
    Loupakis, Fotios
    Rulli, Eliana
    Canestrari, Emanuele
    Santini, Daniele
    Catalano, Vincenzo
    Ficarelli, Rita
    Maltese, Paolo
    Bisonni, Renato
    Masi, Gianluca
    Schiavon, Gaia
    Giordani, Paolo
    Giustini, Lucio
    Falcone, Alfredo
    Tonini, Giuseppe
    Silva, Rosarita
    Mattioli, Rodolfo
    Floriani, Irene
    Magnani, Mauro
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) : 1247 - 1254
12345